Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer

- Murray, Heather C., Dun, Matthew D., Verrills, Nicole M.

Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia

- Toop, Hamish D., Dun, Matthew D., Ross, Bryony K., Flanagan, Hayley M., Verrills, Nicole M., Morris, Jonathan C.

Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

- Dun, Matthew D., Mannan, Abdul, Germon, Zacary, Faulkner, Sam, Chi, Mengna, Skerrett-Byrne, David, Murray, Heather C., Flanagan, Hayley, Almazi, Juhura G., Hondermarck, Hubert, Nixon, Brett, De Iuliis, Geoff, Rigby, Callum J., Chamberlain, J, Alvaro, F, de Bock, CE, Morris, JC, Enjeti, Anoop K., Verrills, Nicole M., Butler, Stephen, Toop, Hamish D., Beck, Dominik, Connerty, Patrick, Sillar, Jonathan, Kahl, Richard G. S., Duchatel, Ryan J.

Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Dephosphorylation of CaMKII at T253 controls the metaphase-anaphase transition

- Hoffman, Alexander, Carpenter, Helen, Kahl, Richard, Watt, Lauren F., Dickson, Phillip W., Rostas, John A. P., Verrills, Nicole M., Skelding, Kathryn A.

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer

- Almazi, Juhura G., Pockney, Peter, Gedye, Craig, Smith, Nathan D., Hondermarck, Hubert, Verrills, Nicole M., Dun, Matthew D.

Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons

- Goldie, Belinda J., Dun, Matthew D., Lin, Minjie, Smith, Nathan D., Verrills, Nicole M., Dayas, Christopher V., Cairns, Murray J.

Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation

- Kranias, Gregory, Watt, Lauren F., Carpenter, Helen, Holst, Jeff, Ludowyke, Russell, Strack, Stefan, Sim, Alistair T. R., Verrills, Nicole M.

Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II

- Skelding, Kathryn A., Rostas, John A. P., Verrills, Nicole M.

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies

- Germon, Zacary P., Sillar, Jonathan R., McLachlan, Tabitha, Schjenken, John E., Skerrett-Byrne, David A., Huang, Honggang, Melo-Braga, Marcella N., Plank, Maximillan W., Alvaro, Frank, Chamberlain, Janis, De Iuliis, Geoff, Aitken, R. John, Mannan, Abdul, Nixon, Brett, Wei, AH, Enjeti, Anoop K., Huang, Y, Lock, RB, Larsen, MR, Lee, Heather, Vaghjiani, V, Cain, JE, de Bock, CE, Duchatel, Ryan J., Verrills, Nicole M., Dun, Matthew D., Staudt, Dilana, Murray, Heather C., Findlay, Izac J., Jackson, Evangeline R., McEwen, Holly P., Douglas, Alicia M.

Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia: an in vivo study

- Verrills, Nicole M., Liem, Natalia L., Liaw, Tracey Y. E., Hood, Brian D., Lock, Richard B., Kavallaris, Maria

Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"

- Perrotti, Danilo, Agarwal, Anupriya, Lucas, Claire M., Narla, Goutham, Neviani, Paolo, Odero, Maria D., Ruvolo, Peter P., Verrills, Nicole M.

Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia

- Murray, Heather C., Miller, Kasey, Brzozowski, Joshua S., Kahl, Richard G. S., Smith, Nathan D., Humphrey, Sean J., Dun, Matthew D., Verrills, Nicole M.

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers

- Roberts, Kathryn G., Smith, Amanda M., Sim, Alistair T. R., Ashman, Leonie K., Verrills, Nicole M., McDougall, Fiona, Carpenter, Helen, Horan, Martin, Neviani, Paolo, Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Perrotti, Danilo

Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease

- Verrills, Nicole M., Irwin, Jennifer A., He, Xiao Yan, Wood, Lisa G., Powell, Heather, Simpson, Jodie L., McDonald, Vanessa M., Sim, Alistair, Gibson, Peter G.

Involvement of vacuolar H⁺₋ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720

- Tay, Kwang Hong, Liu, Xiaoying, Chi, Mengna, Jin, Lei, Jiang, Chen Chen, Guo, Su Tang, Verrills, Nicole M., Tseng, Hsin-Yi, Zhang, Xu Dong

Alterations in γ-actin and tubulin-targeted drug resistance in childhood leukemia

- Verrills, Nicole M., Po'uha, Sela T., Liu, Marjorie L. M., Liaw, Tracy Y. E., Larsen, Martin R., Ivery, Michael T., Marshall, Glenn M., Gunning, Peter W., Kavallaris, Maria

Ppp2r2aKnockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55 alpha, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development

- Panicker, Nikita, Coutman, Melody, Lawlor-O'Neill, Charley, Kahl, Richard G. S., Roselli, Severine, Verrills, Nicole M.

Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells

- Tiburcius, Steffi, Krishnan, Kannan, Vinu, Ajayan, Jose, Linta, Patel, Vaishwik, Ghosh, Arnab, Sathish, C. I., Weidenhofer, Judith, Yang, Jae-Hun, Verrills, Nicole M., Karakoti, Ajay

Essential role of protein phosphatase 2A in metaphase II arrest and activation of mouse eggs shown by okadaic acid, dominant negative protein phosphatase 2A, and FTY720

- Chang, Heng-Yu, Jennings, Phoebe C., Stewart, Jessica, Verrills, Nicole M., Jones, Keith T.